Wuhan Hiteck Biological Pharma Co.,Ltd (SHE:300683)

SHE:300683 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr 28, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022
Market Capitalization	4,621	3,630	3,121	4,727	4,322	7,273
Market Cap Growth	54.08%	16.32%	-33.98%	9.35%	-40.56%	72.12%
Enterprise Value	4,261	2,955	2,310	3,665	3,553	6,267
Last Close Price	35.30	27.73	23.70	35.90	35.19	59.21
PE Ratio	-	-	-	-	-	262.98
Forward PE	-	21.83	21.83	21.83	21.83	21.83
PS Ratio	8.50	6.70	4.81	7.85	6.28	11.83
PB Ratio	2.15	1.67	1.29	1.89	1.85	3.10
P/TBV Ratio	2.66	2.07	1.66	2.44	2.25	3.79
P/OCF Ratio	-	-	137.55	889.42	81.51	601.62
EV/Sales Ratio	7.83	5.46	3.56	6.09	5.16	10.20
EV/EBITDA Ratio	-	-	-	-	203.04	279.54
Debt / Equity Ratio	0.03	0.03	0.02	0.03	0.04	0.04
Debt / EBITDA Ratio	-	-	-	-	4.12	3.64
Net Debt / Equity Ratio	-0.17	-0.34	-0.34	-0.41	-0.41	-0.47
Net Debt / EBITDA Ratio	12.89	26.72	28.40	14.48	-54.50	-49.06
Net Debt / FCF Ratio	4.70	5.89	40.67	6.33	7.89	4.68
Asset Turnover	0.20	0.20	0.22	0.21	0.26	0.25
Inventory Turnover	3.40	3.24	3.37	3.11	3.74	3.75
Quick Ratio	2.58	3.63	3.23	3.88	4.46	5.85
Current Ratio	4.17	3.98	3.60	4.30	5.07	6.35
Return on Equity (ROE)	-10.78%	-10.28%	-3.01%	-5.31%	-0.34%	1.48%
Return on Assets (ROA)	-2.89%	-2.76%	-2.46%	-3.07%	-0.78%	-0.34%
Return on Invested Capital (ROIC)	-7.75%	-8.11%	-7.61%	-9.79%	-2.57%	-1.34%
Return on Capital Employed (ROCE)	-5.50%	-5.40%	-4.50%	-5.30%	-1.40%	-0.50%
Earnings Yield	-5.20%	-6.37%	-2.22%	-2.56%	-0.33%	0.38%
FCF Yield	-1.69%	-3.50%	-0.65%	-3.43%	-2.80%	-3.23%
Dividend Yield	0.37%	-	0.55%	-	-	-
Payout Ratio	-	-	-	-	-	0.22%
Buyback Yield / Dilution	-0.24%	0.14%	-0.71%	-1.86%	-19.91%	-2.00%
Total Shareholder Return	0.12%	0.14%	-0.17%	-1.86%	-19.91%	-2.00%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.